Insider trade

Vivani Medical (VANI): Director reported a gift or transfer of 20K shares

Aaron Mendelsohn, Director at Vivani Medical, reported a gift / transfer of 20K shares.

20K
Shares
Traded
Oct 15, 2026
Filed
Oct 19, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

    What came next

    1. Nov 12, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors (and 1 more item)
    2. Nov 12, 2026Insider · 1 personInsiders: 2 purchases (~$20K)
    View the official recordSEC Form 4

    How to read SEC Form 4

    Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

    Full guide: What is an SEC Form 4?

    What else is on file for Vivani Medical

    For Vivani Medical, OQRO holds 2 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

    These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its VANI page.

    Other recent filings by Aaron Mendelsohn, Director

    The full history of Aaron Mendelsohn, Director is on the profile page.

    How this filing works

    Explore the data

    Other disclosures at Vivani Medical

    Everything OQRO holds on this company is on its VANI page.

    This is one filing. OQRO holds the rest

    Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

    OQRO is free for everyone. No card, no trial

    OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data